BREWIN DOLPHIN LTD - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2019$22,240
-14.3%
3,200
-28.0%
0.00%
-33.3%
Q4 2018$25,965
-22.6%
4,4460.0%0.00%
-25.0%
Q3 2018$33,567
+49.5%
4,4460.0%0.00%
+33.3%
Q2 2018$22,4524,4460.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,563,925$16,717,00029.31%
Cormorant Asset Management, LP 2,000,000$13,580,0001.50%
Perceptive Advisors 2,701,023$18,339,0001.18%
Fosun International Ltd 700,071$4,753,0000.53%
Ghost Tree Capital, LLC 200,000$1,358,0000.22%
ACUTA CAPITAL PARTNERS, LLC 81,302$552,0000.21%
IFP Advisors, Inc 300,000$2,037,0000.11%
CONNING INC. 351,280$2,385,0000.10%
WOODSTOCK CORP 39,931$271,0000.06%
Yellowstone Partners, LLC 15,944$108,0000.04%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders